DexCom Intangible Assets vs Short Term Debt Analysis

DXCM Stock  USD 89.07  4.98  5.92%   
DexCom financial indicator trend analysis is much more than just examining DexCom Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DexCom Inc is a good investment. Please check the relationship between DexCom Intangible Assets and its Short Term Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Intangible Assets vs Short Term Debt

Intangible Assets vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DexCom Inc Intangible Assets account and Short Term Debt. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between DexCom's Intangible Assets and Short Term Debt is 0.53. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of DexCom Inc, assuming nothing else is changed. The correlation between historical values of DexCom's Intangible Assets and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of DexCom Inc are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Intangible Assets i.e., DexCom's Intangible Assets and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.53
Relationship DirectionPositive 
Relationship StrengthWeak

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Short Term Debt

Most indicators from DexCom's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
At this time, DexCom's Selling General Administrative is very stable compared to the past year. As of the 17th of February 2025, Tax Provision is likely to grow to about 203.9 M, while Issuance Of Capital Stock is likely to drop about 19.7 M.

DexCom fundamental ratios Correlations

0.980.960.70.980.551.00.950.950.990.860.940.980.870.970.870.980.980.641.00.970.870.980.930.991.0
0.980.910.750.980.590.990.890.920.970.80.910.960.780.950.790.950.950.730.960.910.790.970.970.980.97
0.960.910.490.90.440.950.980.960.970.930.90.980.920.970.920.950.980.460.980.990.920.960.850.960.96
0.70.750.490.80.570.740.480.540.620.310.710.590.480.570.380.720.580.860.660.530.380.620.720.650.72
0.980.980.90.80.580.990.860.880.940.750.930.930.810.920.750.970.930.770.960.890.750.930.940.970.98
0.550.590.440.570.580.560.420.490.530.220.580.50.40.480.450.510.50.740.510.460.450.530.550.530.54
1.00.990.950.740.990.560.920.930.980.830.940.970.860.950.830.990.960.680.990.950.830.970.940.991.0
0.950.890.980.480.860.420.920.960.960.960.860.980.910.960.950.930.970.390.960.990.950.960.830.920.94
0.950.920.960.540.880.490.930.960.980.910.880.990.90.980.960.890.980.50.960.960.960.980.850.920.94
0.990.970.970.620.940.530.980.960.980.90.921.00.860.980.90.950.980.580.990.980.91.00.910.970.98
0.860.80.930.310.750.220.830.960.910.90.720.920.840.930.90.830.910.180.890.940.90.90.760.840.84
0.940.910.90.710.930.580.940.860.880.920.720.90.860.850.810.940.890.70.940.90.810.910.790.920.95
0.980.960.980.590.930.50.970.980.991.00.920.90.880.990.930.950.990.530.990.990.931.00.90.960.97
0.870.780.920.480.810.40.860.910.90.860.840.860.880.870.910.870.910.410.910.910.910.850.690.850.89
0.970.950.970.570.920.480.950.960.980.980.930.850.990.870.910.930.990.520.970.970.910.980.920.960.95
0.870.790.920.380.750.450.830.950.960.90.90.810.930.910.910.820.920.320.890.941.00.910.70.820.85
0.980.950.950.720.970.510.990.930.890.950.830.940.950.870.930.820.940.620.980.950.820.940.90.970.99
0.980.950.980.580.930.50.960.970.980.980.910.890.990.910.990.920.940.550.980.970.920.980.910.970.97
0.640.730.460.860.770.740.680.390.50.580.180.70.530.410.520.320.620.550.590.450.320.570.710.650.65
1.00.960.980.660.960.510.990.960.960.990.890.940.990.910.970.890.980.980.590.980.890.980.90.981.0
0.970.910.990.530.890.460.950.990.960.980.940.90.990.910.970.940.950.970.450.980.940.970.850.940.96
0.870.790.920.380.750.450.830.950.960.90.90.810.930.910.911.00.820.920.320.890.940.910.70.820.85
0.980.970.960.620.930.530.970.960.981.00.90.911.00.850.980.910.940.980.570.980.970.910.910.960.97
0.930.970.850.720.940.550.940.830.850.910.760.790.90.690.920.70.90.910.710.90.850.70.910.940.91
0.990.980.960.650.970.530.990.920.920.970.840.920.960.850.960.820.970.970.650.980.940.820.960.940.98
1.00.970.960.720.980.541.00.940.940.980.840.950.970.890.950.850.990.970.651.00.960.850.970.910.98
Click cells to compare fundamentals

DexCom Account Relationship Matchups

DexCom fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets4.3B4.9B5.4B6.3B7.2B7.6B
Total Stockholder Equity1.8B2.3B2.1B2.1B2.4B2.5B
Net Debt1.0B769.2M1.4B2.0B2.3B2.4B
Cash817.6M1.1B642.3M566.3M651.2M683.8M
Cash And Short Term Investments2.7B2.7B2.5B2.7B3.1B3.3B
Common Stock Shares Outstanding390M428.8M427.5M425.5M489.3M246.4M
Liabilities And Stockholders Equity4.3B4.9B5.4B6.3B7.2B7.6B
Total Current Assets3.4B3.7B3.7B4.4B5.1B5.3B
Other Current Liab400.3M447.6M753.4M1.2B1.4B1.4B
Total Current Liabilities614.1M720.8M1.8B1.6B1.8B1.9B
Property Plant And Equipment Net608.6M889.9M1.1B1.2B1.4B1.4B
Retained Earnings(202.1M)(47.4M)479.9M1.0B1.2B1.2B
Accounts Payable163.3M189.4M237.9M276.4M317.9M333.8M
Non Current Assets Total865.7M1.2B1.7B1.8B2.1B2.2B
Non Currrent Assets Other21.4M(4.5M)28.1M36.5M42.0M44.1M
Other Assets14.2M237.8M220.8M369.3M424.7M445.9M
Non Current Liabilities Total1.8B1.9B1.4B2.6B3.0B3.2B
Other Current Assets107.8M79.3M153.7M154.7M177.9M186.8M
Other Stockholder Equity2.0B1.9B1.7B1.1B1.2B1.3B
Total Liab2.5B2.6B3.3B4.2B4.8B5.1B
Property Plant And Equipment Gross608.6M801.8M1.1B1.7B1.9B2.0B
Accumulated Other Comprehensive Income3.2M500K(11.6M)(16.7M)(15.0M)(14.3M)
Property Plant Equipment321.3M515.3M889.9M1.1B1.3B1.4B
Other Liab5.7M80.9M90M68.7M79.0M83.0M
Short Term Investments1.9B1.7B1.8B2.2B2.5B2.6B
Short Long Term Debt Total1.8B1.8B2.1B2.6B3.0B3.1B
Long Term Debt1.7B1.7B1.2B2.4B2.8B2.9B
Net Receivables428.5M516.6M752.2M987.5M1.1B1.2B
Inventory234.7M357.3M306.7M559.6M643.5M675.7M
Short Term Debt33M41M793.1M21.1M24.3M23.1M
Current Deferred Revenue2.2M2.1M10.1M18.4M21.2M22.2M
Net Tangible Assets864M1.8B2.2B2.1B2.5B2.6B
Good Will19.3M26.5M25.7M25.2M29.0M30.4M
Retained Earnings Total Equity(695.7M)(202.1M)(47.4M)479.9M551.9M579.5M
Capital Surpluse1.7B2.1B2.5B2.3B2.6B1.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.39)
Earnings Share
1.42
Revenue Per Share
10.246
Quarterly Revenue Growth
0.076
Return On Assets
0.0615
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.